Chapter 12: Biotechnology and Synthetic Biology

Genetic engineering relies on a variety of in vitro techniques that allow scientists to isolate, amplify, modify, and analyze genetic material, including polymerase chain reaction for DNA amplification, gel electrophoresis for separating nucleic acids by size, and nucleic acid hybridization methods that detect specific DNA or RNA sequences through complementary base pairing. Molecular cloning enables the construction of recombinant DNA molecules by inserting genes into vectors such as plasmids, viruses, or artificial chromosomes using restriction enzymes and DNA ligase, followed by introduction of these vectors into host organisms like Escherichia coli or yeast. Additional genetic techniques such as recombineering, site directed mutagenesis, gene disruption, and cassette mutagenesis allow precise modification of genes to investigate protein function or improve biochemical activity. Reporter genes such as lacZ and green fluorescent protein are widely used to study gene regulation through gene fusions that link detectable markers to regulatory sequences. Biotechnology applications harness genetically engineered microorganisms to produce valuable products including therapeutic proteins, vaccines, and biofuels. Microbial expression systems are used to manufacture pharmaceuticals such as human growth hormone, clotting factors, and tissue plasminogen activator, while transgenic organisms in agriculture incorporate foreign genes to provide beneficial traits like insect resistance. Recombinant vaccine technologies include attenuated pathogens, vector based vaccines, and purified subunit vaccines produced through microbial expression systems. Engineered commensal microbes and antibody delivery systems are also being explored for targeted therapeutic treatments such as anticancer drug delivery. Advances in synthetic biology extend these approaches by assembling standardized biological components known as biobricks into artificial metabolic pathways, biosensors, and genetic circuits capable of performing programmed biological functions. Synthetic genomes have even been constructed to create minimal cells with reduced gene sets that support life. The chapter concludes with genome editing technologies such as CRISPR Cas systems, which use RNA guided nucleases to introduce precise genetic changes, along with emerging technologies such as gene drives designed to spread engineered traits through populations and biocontainment strategies that restrict the environmental spread of genetically modified organisms.